Status:
COMPLETED
Retinal Vessel Diameter in Branch Retinal Vein Occlusion
Lead Sponsor:
Kyungpook National University Hospital
Conditions:
Branch Retinal Vein Occlusion
Eligibility:
All Genders
40-85 years
Brief Summary
The authors investigated the consecutive change of retinal vessel's diameter in affected eye and fellow eye of Branch Retinal Vein Occlusion.
Detailed Description
Twenty five consecutive patients who had undergone intravitreal bevacizumab injection for Branch Retinal Vein Occlusion with macular edema were included in this study. All subjects were enrolled betwe...
Eligibility Criteria
Inclusion
- Best-corrected visual acuity less than 20/40
- Central subfield macular thickness (CSMT) 300 μm or greater on spectral-domain optical coherence tomography
Exclusion
- Patients with recurrent BRVO
- History of previous treatments for BRVO including vitreoretinal surgery, intravitreal injection, subtenon injection or laser photocoagulation
- Patients with diabetes or dyslipidemia
- IOP ≥ 22mmHg, treatment for glaucoma, a family history of glaucoma, or optic neuropathy
- High myopia (\<-6 Diopters), high hyperopia (\>6 Diopters) or a history of refractive surgeries
- Co-existing retinal disease other than BRVO
- Corneal diseases include ulcer, keratoconus and a history of corneal laceration
- Cataract and other media opacities resulting in visual impairment or poor fundus images
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT02215109
Start Date
April 1 2012
End Date
August 1 2016
Last Update
August 30 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dong Ho Park
Daegu, Kyungsangpookdo, South Korea, 700-721